-
US suspends green card lottery after Brown, MIT professor shootings
-
Chelsea's Maresca says Man City link '100 percent' speculation
-
Dominant Head moves into Bradman territory with fourth Adelaide ton
-
Arsenal battle to stay top of Christmas charts
-
Mexican low-cost airlines Volaris and Viva agree to merger
-
Border casinos caught in Thailand-Cambodia crossfire
-
Australia's Head slams unbeaten 142 to crush England's Ashes hopes
-
Epstein files due as US confronts long-delayed reckoning
-
'Not our enemy': Rush to rearm sparks backlash in east Germany
-
West Indies 110-0, trail by 465, after Conway's epic 227 for New Zealand
-
Arsonists target Bangladesh newspapers after student leader's death
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Tears at tribute to firefighter killed in Hong Kong blaze
-
Seahawks edge Rams in overtime thriller to seize NFC lead
-
Teenager Flagg leads Mavericks to upset of Pistons
-
Australia's Head fires quickfire 68 as England's Ashes hopes fade
-
Conway falls for 227 as New Zealand declare at 575-8 in West Indies Test
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
Conway falls for 227 as New Zealand pass 500 in West Indies Test
-
'We are ghosts': Britain's migrant night workers
-
Asian markets rise as US inflation eases, Micron soothes tech fears
-
Giant lanterns light up Christmas in Catholic Philippines
-
TikTok: key things to know
-
Putin, emboldened by Ukraine gains, to hold annual presser
-
Deportation fears spur US migrants to entrust guardianship of their children
-
Upstart gangsters shake Japan's yakuza
-
Trump signs $900 bn defense policy bill into law
-
Stokes's 83 gives England hope as Australia lead by 102 in 3rd Test
-
Go long: the rise and rise of the NFL field goal
-
Australia announces gun buyback, day of 'reflection' after Bondi shooting
-
New Zealand Cricket chief quits after split over new T20 league
-
England all out for 286, trail Australia by 85 in 3rd Test
-
Australian announces gun buyback, day of 'reflection' after Bondi shooting
-
Joshua takes huge weight advantage into Paul fight
-
TikTok signs joint venture deal to end US ban threat
-
Conway's glorious 200 powers New Zealand to 424-3 against West Indies
-
WNBA lockout looms closer after player vote authorizes strike
-
Honduras begins partial vote recount in Trump-dominated election
-
Nike shares slump as China struggles continue
-
Hundreds swim, float at Bondi Beach to honour shooting victims
-
Crunch time for EU leaders on tapping Russian assets for Ukraine
-
Pope replaces New York's pro-Trump Cardinal with pro-migrant Chicagoan
-
Trump orders marijuana reclassified as less dangerous drug
-
Rams ace Nacua apologizes over 'antisemitic' gesture furor
-
McIlroy wins BBC sports personality award for 2025 heroics
-
Napoli beat Milan in Italian Super Cup semi-final
-
Violence erupts in Bangladesh after wounded youth leader dies
-
EU-Mercosur deal delayed as farmers stage Brussels show of force
-
US hosting new Gaza talks to push next phase of deal
Kenya's desperate need for more snake antivenom
Writhing in pain on a hospital bed in a Kenyan coastal town, teenage snakebite victim Shukurani Konde Tuva faced the grim reality of his left leg from above the knee being amputated.
The 14-year-old was bitten by a puff adder -- a venomous snake and the most common snakebite in sub-Saharan Africa -- while eating outdoors in his village near the town of Malindi more than a month ago.
His family rushed him to hospital two hours away by motorbike, but the antivenom he received did not help.
"My son's leg is totally rotten and maggots are even emanating from it. They'll have to cut it," said his distraught mother, Mariamu Kenga Kalume.
Some 5.4 million people are bitten by snakes each year globally and roughly half are poisoned by venom, according to World Health Organization (WHO) data.
Up to 138,000 people die and 400,000 suffer permanent physical effects, though the WHO says the numbers are a "gross underestimation" since an estimated 70 percent of cases go unreported.
Traditional beliefs and myths skew the data as some victims turn to home-grown remedies or attribute bites to voodoo "sent by their enemies" instead of seeking medical care.
- 'Snake stone' -
A few kilometres (miles) from where Shukurani lay in pain, traditional healer Douglas Rama Bajila showed AFP the concoctions he uses to "suck out" venom.
One popular remedy is the "snake stone", made from a cow's bone and sold for about $1.
Bajila said it can be reused multiple times: it simply needs to be soaked in milk for a few hours to "recharge".
One was placed on Shukurani's leg as he was transported to hospital but unfortunately fell off along the way, his mother said.
Experts worry that by using traditional snakebite remedies, patients are losing precious time but they are popular because antivenom treatments are expensive.
Antivenoms cost up to 8,000 shillings (about $62) per vial, and some patients require as many as 20 doses.
Ruth Kintalel, 30, from a pastoralist community in Kajiado county near the capital Nairobi, said she spent over five months in hospital after a red spitting cobra bit her in her sleep.
"My husband sold our livestock to cover the rising hospital bill," said Kintalel, who is still paralysed in her right arm seven years later.
- 'Bad reactions' -
Experts say Kenya receives between 10,000 and 30,000 vials of antivenom per year and needs 100,000.
Antivenom is made by "milking" venom from the fangs of snakes, which is then diluted and injected in small doses into animals such as horses, which produce antibodies that can be extracted for use in humans.
Using snakes from different regions, even of the same species, can reduce the effectiveness of the antivenom and cause "really bad reactions", said Kyle Buster Ray, a curator at the Watamu Snake Farm on the Kenyan coast.
Kenya's stock of antivenom is not always effective because much comes from other countries like India, he said.
His farm houses over 400 venomous and non-venomous snakes and seeks to re-establish faith in antivenom that has been undermined by too many shoddy treatments.
It offers free antivenom to critical cases locally, but stocks are limited.
The farm also trains communities in life-saving snakebite responses.
During a session attended by AFP, about half the community said they had been bitten at least once, and nearly all had initially turned to traditional medicines.
Many showed signs of paralysis, with one suffering partial blindness.
- 'Trauma' -
In Nairobi, the Snakebite Research and Intervention Centre within the Kenya Institute of Primate Research is working on an antivenom specific to the country and applicable to multiple species.
Valentine Musabyimana, a research fellow at the institute, said they "are aiming for an antivenom where a patient will require only one vial with great potency".
Government subsidies should make it affordable, she hopes, though it is expected to take about two years before the antivenom is available.
That is too late for 14-year-old Shukurani.
At the snake farm, Ray warned that the boy faced psychological as well as physical consequences.
"Someone has watched their limb completely rot... there's a lot of mental trauma," Ray said.
J.Horn--BTB